作者: Takaaki Kobayashi , David K. C. Cooper
DOI: 10.1007/978-1-4615-4771-6_10
关键词:
摘要: Significant progress in clinical transplantation has been achieved through the development of improved immunosuppressive therapy during past two decades. Transplantation is clearly established as treatment choice for many patients suffering from end-stage organ failure. Although number donors becoming available slowly increased, relative shortage caused by extended indications become critical. Attention now being focused on xenotransplantation—using animal organs, tissues or cells—as a potential and promising solution to this serious problem (Cooper, 1993a).